pregna-1,4,20-trien-3-one | 65754-63-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: pregna-1,4,20-trien-3-one
• 英文别名: 1,4,20-pregnatrien-3-one；(8S,9S,10R,13R,14S,17R)-17-ethenyl-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
• CAS: 65754-63-4
• 化学式: C₂₁H₂₈O
• 分子量: 296.453
• InChiKey: KFTYFBOHSUEIEJ-NWSAAYAGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  22
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  pregna-1,4,20-trien-3-one 在 palladium on activated charcoal 氢气 作用下， 生成 (5α)-pregnan-3-one
  参考文献：
  名称：

  5α-pregna-1, 20-dien-3-one and related compounds from a soft coral

  摘要：

  Four unusual pregnane derivatives, 5alpha-pregna-1,20-dien-3-one (1), 1,4,20-pregnatrien-3-one (3), 5alpha-pregn-20-en-3alpha-o1 o-acetate (4), and 5alpha-pregn-20-en-1alpha,3alpha-diol 3-acetate (6) have been isolated from an unidentified soft coral from Canton Island.

  DOI：

  10.1016/0039-128x(77)90028-9
• 作为产物：
  描述：

  5α-Pregna-1,20-dien-3-on 在 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 苯 为溶剂， 生成 pregna-1,4,20-trien-3-one
  参考文献：
  名称：

  5α-pregna-1, 20-dien-3-one and related compounds from a soft coral

  摘要：

  Four unusual pregnane derivatives, 5alpha-pregna-1,20-dien-3-one (1), 1,4,20-pregnatrien-3-one (3), 5alpha-pregn-20-en-3alpha-o1 o-acetate (4), and 5alpha-pregn-20-en-1alpha,3alpha-diol 3-acetate (6) have been isolated from an unidentified soft coral from Canton Island.

  DOI：

  10.1016/0039-128x(77)90028-9

文献信息

• Steroids as neurochemical initiators of change in human blood levels of
  申请人：Pherin Corporation

  公开号：US06066627A1

  公开（公告）日：2000-05-23

  The invention relates to a method of altering the blood levels of LH or FSH in an individual. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.

  该发明涉及一种改变个体血液中LH或FSH水平的方法。该方法包括经鼻给药一种类固醇物质，该类固醇物质是一种人类嗅觉素，使得该嗅觉素结合到特定的神经上皮受体上。该类固醇或多种类固醇最好以含有一个或多个药用载体的制药组合物的形式给药。
• Steroids as neurochemical stimulators of the VNO to alleviate symptoms
  申请人：Pherin Corporation

  公开号：US06057439A1

  公开（公告）日：2000-05-02

  The invention relates to a method of alleviating the symptoms of PMS and anxiety. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.

  该发明涉及一种缓解经前期综合征和焦虑症状的方法。该方法包括通过鼻腔给药一种类固醇物质，即一种人类呕吐素，使得呕吐素与特定的神经上皮受体结合。所述类固醇物质通常以含有一种或多种药用载体的药物组合物的形式给予。
• Steroids as neurochemical stimulators of the VNO to treat paroxistic
  申请人：Pherin Pharmaceuticals, Inc.

  公开号：US06117860A1

  公开（公告）日：2000-09-12

  The invention relates to a method of alleviating the symptoms of PMS and anxiety. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.

  该发明涉及一种缓解经前期综合症和焦虑症状的方法。该方法包括经鼻给药一种类固醇物质，即人类呕吐素，使得呕吐素与特定的神经上皮受体结合。该类固醇物质或多种类固醇物质最好以含有一种或多种药用载体的药物组合物的形式给予。
• Steroids as neurochemical stimulators of the VNO to alleviate pain
  申请人：Pherin Pharmaceuticals, Inc.

  公开号：US06331534B1

  公开（公告）日：2001-12-18

  The invention relates to a method of alleviating pain. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.

  该发明涉及一种缓解疼痛的方法。该方法包括经鼻给药一种类固醇，该类固醇为一种人类呕吐素，使得呕吐素与特定的神经上皮受体结合。该类固醇或多种类固醇最好以含有一种或多种药用载体的制药组合物的形式给予。
• Pregnane steroids as neurochemical initiators of change in human
  申请人：Pherin Corporation

  公开号：US05563131A1

  公开（公告）日：1996-10-08

  The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human vomeropherin, e.g. a pregnane steroid, or a pharmaceutical composition containing a vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.

  该发明涉及改变个体下丘脑功能的方法。该方法包括经鼻给药人类呕吐素，例如孕烷类类固醇，或含有呕吐素的药物组合物，使呕吐素与特定的神经上皮受体结合。该类固醇通常以含有一个或多个药用载体的药物组合物的形式给药。该发明的其他实施方式包括含有这些类固醇的药物组合物。